Allulose
4 benefits mapped to clinical evidence across supplements.
Dose per serving from research
21 study groups in 9 studies say how much Allulose participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 2.5 g to 5 g and 5 g to 10 g, 33% of 21 study groups each.
| Daily dose | Study groups |
|---|---|
| 1 g to 2.5 g | 4 |
| 2.5 g to 5 g | 7 |
| 5 g to 10 g | 7 |
| 10 g to 25 g | 1 |
| 25 g to 50 g | 2 |
Benefit Evidence
Research sources
Weight management (5)
- A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial
PubMed ID: 29385054
12‑week randomized trial in overweight adults showed reductions in body fat, body fat % and BMI (dose‑dependent).
- Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects
PubMed ID: 20208358
Human RCTs with D-psicose/allulose demonstrate feasibility of replacing sugar and lowering glycemic load.
- Randomized Trial to Assess the Safety and Tolerability of Daily Intake of an Allulose Amino Acid-Based Hydration Beverage in Men and Women
PubMed ID: 38892699
Short-term tolerability of an allulose beverage supports real-world use to manage sugar intake.
- Effects of D-Allulose with Sucrose Beverage on Glucose Tolerance and Insulin Levels among Thai Healthy Volunteers
PubMed ID: 38945885
Dose-dependent attenuation of sucrose-induced glycemia indicates utility in managing effective sugar exposure.
- Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study
PubMed ID: 33637605
Adding allulose to sucrose reduced early glycemic impact, supporting its use to blunt sugar effects in mixed foods/beverages.
Metabolism (3)
- Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study
PubMed ID: 33637605
Dose-dependent reduction in early post-sucrose glucose and insulin supports metabolic effects.
- Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects
PubMed ID: 20208358
Single-dose reductions in postprandial glucose and 12-week safety data indicate metabolic relevance.
- A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial
PubMed ID: 29385054
12-week trial showed reduced body fat, BMI and some abdominal fat—favors improved metabolic profile.
Blood sugar (3)
- Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects
PubMed ID: 20208358
Randomized data showing single 5 g doses reduced postprandial glucose and AUC in some participants.
- Effects of D-Allulose with Sucrose Beverage on Glucose Tolerance and Insulin Levels among Thai Healthy Volunteers
PubMed ID: 38945885
Clear dose-response suppression of sucrose-induced glycemia in healthy volunteers.
- Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study
PubMed ID: 33637605
Dose-dependent reduction in early post-sucrose glucose and decreased excursion at higher doses.
Fat burn (1)
- A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial
PubMed ID: 29385054
Largest clinical trial in dataset: 12 weeks of an allulose beverage decreased body fat mass, body fat % and BMI (dose-dependent).
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Allulose
Search all25 products whose verified label declares Allulose — not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.